Literature DB >> 23627612

Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction.

Johan Mårtensson1, Max Bell, Shengyuan Xu, Matteo Bottai, Bo Ravn, Per Venge, Claes-Roland Martling.   

Abstract

OBJECTIVE: Neutrophil gelatinase-associated lipocalin (NGAL) is secreted by injured kidney cells as well as by activated neutrophils in response to bacterial infections. We assessed the influence of acute renal dysfunction on the association between plasma NGAL and sepsis.
METHODS: NGAL was measured daily in 138 critically ill patients. Simultaneous recordings of sepsis status and fluctuations in renal function were made.
RESULTS: Elevated NGAL was associated with sepsis independent of level of acute renal dysfunction. A cut-off value of 98 ng/mL distinguished sepsis from systemic inflammation with high sensitivity (0.77) and specificity (0.79).
CONCLUSIONS: Plasma NGAL can help clinicians to identify bacterial infections in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23627612     DOI: 10.3109/1354750X.2013.787460

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  15 in total

1.  Analysis of blood markers for early breast cancer diagnosis.

Authors:  J Bayo; M A Castaño; F Rivera; F Navarro
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

2.  Clinical evaluation of multiple inflammation biomarkers for diagnosis and prognosis for patients with systemic inflammatory response syndrome.

Authors:  M Reichsoellner; R B Raggam; J Wagner; R Krause; M Hoenigl
Journal:  J Clin Microbiol       Date:  2014-09-03       Impact factor: 5.948

Review 3.  Neutrophil gelatinase-associated lipocalin and innate immune responses to bacterial infections.

Authors:  Dimitrios Nasioudis; Steven S Witkin
Journal:  Med Microbiol Immunol       Date:  2015-02-26       Impact factor: 3.402

4.  CSF lipocalin-2 increases early in subarachnoid hemorrhage are associated with neuroinflammation and unfavorable outcome.

Authors:  Fang Yu; Aisha Saand; Changhong Xing; Jong Woo Lee; Liangge Hsu; Octavia P Palmer; Vanessa Jackson; Lu Tang; MingMing Ning; Rose Du; Patrick M Kochanek; Eng H Lo; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2021-05-05       Impact factor: 6.200

Review 5.  Acute kidney injury after lung transplantation: a narrative review.

Authors:  Lei Jing; Wenhui Chen; Lijuan Guo; Li Zhao; Chaoyang Liang; Jingyu Chen; Chen Wang
Journal:  Ann Transl Med       Date:  2021-04

6.  The identification of neutrophils-mediated mechanisms and potential therapeutic targets for the management of sepsis-induced acute immunosuppression using bioinformatics.

Authors:  Fang Chen; Chunyan Yao; Yue Feng; Ying Yu; Honggang Guo; Jing Yan; Jin Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

7.  Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.

Authors:  Max Bell; Anders Larsson; Per Venge; Rinaldo Bellomo; Johan Mårtensson
Journal:  Dis Markers       Date:  2015-03-18       Impact factor: 3.434

8.  The role of leptospiremia and specific immune response in severe leptospirosis.

Authors:  Umaporn Limothai; Nuttha Lumlertgul; Phatadon Sirivongrangson; Win Kulvichit; Sasipha Tachaboon; Janejira Dinhuzen; Watchadaporn Chaisuriyong; Sadudee Peerapornratana; Chintana Chirathaworn; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Kriang Tungsanga; Nattachai Srisawat
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

9.  A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers.

Authors:  Tom Nilsen; Kathrin Sunde; Anders Larsson
Journal:  J Inflamm (Lond)       Date:  2015-07-25       Impact factor: 4.981

10.  Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients.

Authors:  Johan Mårtensson; Niklas Jonsson; Neil J Glassford; Max Bell; Claes-Roland Martling; Rinaldo Bellomo; Anders Larsson
Journal:  Ann Intensive Care       Date:  2016-01-13       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.